Khan, Hamza http://orcid.org/0000-0002-0398-4848
Geys, Lotte http://orcid.org/0000-0003-1919-9366
Baneke, Peer
Comi, Giancarlo
Peeters, Liesbet M.
Article History
Received: 1 June 2023
Accepted: 16 January 2024
First Online: 31 January 2024
Competing interests
: The operational costs linked to this study are funded by the Multiple Sclerosis International Federation (MSIF) and the Multiple Sclerosis Data Alliance (MS Data Alliance), acting under the umbrella of the European Charcot Foundation (ECF: ExternalRef removed). The MS Data Alliance received income from a range of corporate sponsors, including Biogen, Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck, Novartis, and Roche. MSIF also receives income from a number of corporate sponsors, recently including Biogen, Bristol-Myers Squibb, Coloplast, Janssen, Merck, Mylan, Novartis, Roche and Sanofi – all of which is publicly disclosed. In addition, the authors involved in this research have no conflicts of interest to report that are relevant to this study.